05 May

Posted at 01:25h in Blog, Latest News, News, Pharmaceutical by
0 Likes

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text css=""]U.S. producer secures ANVISA protocol numbers, targets Brazil’s healthcare market with compliant cannabinoid offerings   Greeley, Colorado, May 6, 2025 – Vantage Hemp Co. (“Vantage” or “the Company”), a globally accredited cannabinoid extractor and manufacturer, has initiated its regulatory...

09 Feb

Posted at 18:07h in Blog, Top Blogs by
0 Likes

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text css=".vc_custom_1744246567177{padding-bottom: 32px !important;}"]Recent regulatory changes have simplified the process for importing cannabis-derived active pharmaceutical ingredients (APIs), such as CBD Isolate, into the Brazilian market. These adjustments reflect a shift in Brazil’s approach, aligning more closely with...